The RNAseq data (level 3) of NSCLC samples and the corresponding clinically informative expression distribution of PDLIM5 in tumour and normal tissues from TCGA were obtained (https://portal.gdc.com). This evidence concerns the gene PDLIM5 and non-small cell lung carcinoma.